logo

For the Inventor, By the Inventor

Shrewsbury, MA, United States of America

Suju Zhong

This inventor holds 7 USPTO granted patents and 4 published patent applications. Top assignee: Abbvie Inc.. Active years: 2014-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suju Zhong. Retrieved from https://idiyas.com/inventor/suju-zhong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 85.7

Average Co-Inventor Count = 10.6

ph-index = 4

Forward Citations = 65(Granted Patents)


Company Filing History:

goldMedal7 out of 827 
 
Abbvie Inc.
 patents

Years Active: 2014-2017

Loading Chart...
7 patents (USPTO):Explore Patents
1. 9803009 - Immunobinders directed against TNF (2017-10-31),
2. 9663587 - IL-17 binding proteins (2017-05-30),
3. 9655964 - Bispecific antibodies directed against TNF-α and IL-17 (2017-05-23),
4. 9481736 - IL-17 binding proteins (2016-11-01),
5. 9481735 - IL-17 binding proteins (2016-11-01),
6. 8835610 - IL-17 binding proteins (2014-09-16),
7. 8779101 - IL-17 binding proteins (2014-07-15),

Title: The Innovations of Suju Zhong: A Pioneer in Therapeutic Proteins

Introduction: Suju Zhong, an accomplished inventor based in Shrewsbury, MA, has made significant contributions to the field of biotechnology with a portfolio of seven patents. His work primarily focuses on developing antibodies and binding proteins that target specific diseases, showcasing his commitment to advancing medical research and therapeutic options.

Latest Patents: Among Suju Zhong's most recent innovations are groundbreaking patents for immunobinders aimed at tumor necrosis factor-alpha (TNF-α). These isolated binding proteins include antibodies and are crucial for therapeutic applications. His patent also covers the pharmaceutical compositions that comprise these antibodies, alongside novel methods for diagnosing and treating related conditions. Furthermore, he has developed IL-17 binding proteins, which have transformative potential for treating IL-17 related diseases. This patent encompasses methods for detecting IL-17 in various samples, underscoring the importance of these innovative solutions in medical diagnostics and treatment.

Career Highlights: Suju Zhong's career at AbbVie Inc. has positioned him as a key figure in the biotechnology sector. His extensive research and inventive spirit have not only led to numerous patents but have also contributed to advancements in therapeutic strategies for complex diseases.

Collaborations: Throughout his career, Suju Zhong has worked alongside accomplished professionals like Chung-Ming Hsieh and Yuliya Kutskova. These collaborations highlight the importance of teamwork in the research community, fostering advancements that benefit public health and medical science.

Conclusion: Suju Zhong exemplifies the innovative spirit in the field of biotechnology. His focus on developing novel therapeutic proteins and methods demonstrates his dedication to addressing significant health challenges. With seven patents to his name and ongoing contributions at AbbVie Inc., Zhong’s work will undoubtedly continue to influence the landscape of medical research and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…